Delay Dynamics of Cancer and Immune Cell Model
Mathematical Modelling of Natural Phenomena (2012)
- Volume: 7, Issue: 1, page 261-278
- ISSN: 0973-5348
Access Full Article
top
Abstract
topHow to cite
topAdongo, D., and Fister, K.R.. "Delay Dynamics of Cancer and Immune Cell Model." Mathematical Modelling of Natural Phenomena 7.1 (2012): 261-278. <http://eudml.org/doc/222381>.
@article{Adongo2012,
abstract = {We investigate optimal control of a cancer-immune cell interactive model with delay in
the interphase compartment. By applying the optimal control theory, we seek to minimize
the cost associated with the chemotherapy drug, minimize the accumulation of cancer cells,
and increase the immune cell presence. Optimality conditions and characterization of the
control are provided. Numerical analyses are given to enhance the understanding of the
difficulties that occur in the control of cancer.},
author = {Adongo, D., Fister, K.R.},
journal = {Mathematical Modelling of Natural Phenomena},
keywords = {optimal control; chemotherapy drug; cancer cells},
language = {eng},
month = {1},
number = {1},
pages = {261-278},
publisher = {EDP Sciences},
title = {Delay Dynamics of Cancer and Immune Cell Model},
url = {http://eudml.org/doc/222381},
volume = {7},
year = {2012},
}
TY - JOUR
AU - Adongo, D.
AU - Fister, K.R.
TI - Delay Dynamics of Cancer and Immune Cell Model
JO - Mathematical Modelling of Natural Phenomena
DA - 2012/1//
PB - EDP Sciences
VL - 7
IS - 1
SP - 261
EP - 278
AB - We investigate optimal control of a cancer-immune cell interactive model with delay in
the interphase compartment. By applying the optimal control theory, we seek to minimize
the cost associated with the chemotherapy drug, minimize the accumulation of cancer cells,
and increase the immune cell presence. Optimality conditions and characterization of the
control are provided. Numerical analyses are given to enhance the understanding of the
difficulties that occur in the control of cancer.
LA - eng
KW - optimal control; chemotherapy drug; cancer cells
UR - http://eudml.org/doc/222381
ER -
References
top- I. Athanassios, D. Barbolosi. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model. Compu. Biomedical Res., 33 (2000), 211–226.
- M. Chaplain, A. Matzavinos. Mathematical modelling of spatio-temporal phenomena in tumour immunology tutorials in mathematical biosciences III. Cell Cycle, Proliferation, and Cancer, (2006), 131–183.
- W. Cheney, D. Kincaid. Numerical mathematics and computing. Thomson Brooks/Cole, Belmont, 2008.
- C. Collins, K. R. Fister, M. Williams. Optimal control of a cancer cell model with delay. Math. Model. Nat. Phen., 5 (2010), No. 3, 63–71.
- P. C. Das, R. R. Sharma. On optimal controls for measure delay-differential equations. SIAM J. Control, 6 (1971), No. 1, 43–61.
- L. G. dePillis, A. E. Radunskaya. A mathematical tumor model with immune resistance and drug therapy : an optimal control approach. J. Theoretical Medicine, 3 (2001), 79–100.
- L. G. dePillis, A. E. Radunskaya. The dynamics of an optimally controlled tumor model : a case study. Math. Comp. Model., 37 (2003), No. 11, 1221–1244.
- L. G. dePillis, A. E. Radunskaya, C. L. Wiseman. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Research, 61 (2005), No. 17, 7950–7958.
- L. G. dePillis, K. R. Fister, W. Gu, C. Collins, M. Daub, J. Moore, B. Preskill. Mathematical model creation for cancer chemo-immunotherapy. Computational and Math. Methods in Medicine, 10 (2009), No. 3, 165–184.
- R. D. Driver. Ordinary and delay differential equations. Springer-Verlag, New York, 1977.
- R. Fletcher. Practical methods of optimization. Wiley and Sons, New York, 1987.
- W. Lu, T. Hillen, H. I. Freedman. A mathematical model for M-phase specific chemotherapy including the Go-phase and immunoresponse. Math. Biosci. and Engng., 4 (2007), No. 2, 239–259.
- M.I. Kamien, N. L. Schwartz. Dynamic optimization : the calculus of variations and optimal control in economics and management, Advanced Textbooks in Economics. North-Holland, 1991.
- M. Kim, S. Perry, K. B. Woo. Quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory. Ann. Biomed. Engng, 5 (1977), 12–33.
- D. Kirschner, J. C. Panetta. Modeling immunotherapy of the tumor-immune interaction. J. Math. Bio., 35 (1998), 235–252.
- U. Ledzewicz, T. Brown, H. Schattler. Comparison of optimal controls for a model in cancer chemotherapy with l1 and l2 type objectives. Optimization Methods and Software, 19 (2004), No. 3-4, 339–350.
- U. Ledzewicz, H. Schattler. Drug resistance in cancer chemotherapy as an optimal control problem. Discrete and Continuous Dynamical Systems - Series B, 6 (2006), No. 1, 129–150.
- D. McKenzie. Mathematical modeling and cancer. SIAM News, 31 (2004), 1–2.
- J. M. Murray. Some optimality control problems in cancer chemotherapy with a toxicity limit. Math. Biosci., 100 (1990), 49–67.
- L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze, E. F. Mishchenko. The mathematical theory of optimal processes. Gordon and Breach, 1962.
- G. W. Swan, T. L. Vincent. Optimal control analysis in the chemotherapy of IgG multiple myeloma. Bull. of Math. Bio., 39 (1977), 317–337.
- A. Swierniak, U. Ledzewicz, H. Schattler. Optimal control for a class of compartmental models in cancer chemotherapy. Int. J. Appl. Math. Comput. Sci., 13 (2003), No. 3, 357–368.
- M. Villasana A. Radunskaya. A delay differential equation model for tumor growth. J. Math. Bio., 47 (2003), 270–294.
NotesEmbed ?
topYou must be logged in to post comments.
To embed these notes on your page include the following JavaScript code on your page where you want the notes to appear.